You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 98 NX-0255, a small molecule CBL-B inhibitor, expands and enhances tumor infiltrating lymphocytes (TIL) for use in adoptive cancer immunotherapy

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
98 NX-0255, a small molecule CBL-B inhibitor, expands and enhances tumor infiltrating lymphocytes (TIL) for use in adoptive cancer immunotherapy
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to August 2024

AbstractFullPdf
Nov 2021342047
Dec 2021110030
Jan 2022174054
Feb 2022216053
Mar 2022550050
Apr 2022390057
May 2022288067
Jun 2022340048
Jul 2022302044
Aug 2022316052
Sep 2022336050
Oct 2022330043
Nov 2022240025
Dec 2022196019
Jan 2023238037
Feb 2023256040
Mar 2023188028
Apr 2023162025
May 2023154022
Jun 2023120013
Jul 2023114019
Aug 2023100019
Sep 20237207
Oct 20235602
Nov 2023128015
Dec 20238609
Jan 20244209
Feb 202466015
Mar 202474026
Apr 202486015
May 20243207
Jun 20244004
Jul 202460013
Aug 202442011
Total62460975